This compound is primarily utilized in the field of medicinal chemistry as an intermediate in the synthesis of various biologically active molecules. Its structure, featuring a trifluoromethylphenyl group and a morpholine ring, makes it a valuable building block for developing compounds with potential therapeutic applications. It is often employed in the research and development of drugs targeting neurological disorders, such as depression and anxiety, due to its ability to interact with specific receptors in the brain. Additionally, its use extends to the study of enzyme inhibitors, particularly those involved in metabolic pathways, contributing to the discovery of new treatments for metabolic diseases. The compound's stability and reactivity also make it a useful reagent in organic synthesis, aiding in the creation of complex molecules for further pharmacological evaluation.